Jurek Sikorski
Signal active
Executive in Residence
Bio
Jurek is Executive in Residence at the London Business School and non-Executive Director of AIM listed Intercede Group Plc.
Jurek has over 30 years’ experience in the pharmaceutical, medical devices, in vitro diagnostics and biotechnology industries.This includes roles as the Chief Executive of SRS Technology Group Plc, Cantab Pharmaceuticals Plc and Proteus International Plc.
Jurek has led IPO and secondary fund raising and negotiated M&A, distribution, license and developments agreements with large corporates including Tunstall, the UK largest Telecare provider.
Location
Reading, Reading, United Kingdom, Europe
Social
Primary Organization
London Business School
Founded
1964
Employees
501-1000
Industry
Education, Training, Higher Education
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Jurek Sikorski is the Executive in Residence at London Business School, based in Europe. With a background in Education, Jurek Sikorski has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
10
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| May 11, 2022 | - | Seed Round - Mayku | - | 1.8M |
| Oct 27, 2022 | Nix & Kix | Seed Round - Nix & Kix | - | 1.2M |
| Dec 16, 2022 | Fact360 | Angel Round - Fact360 | - | 607.2K |
| Oct 30, 2023 | Airponix.com | Venture Round - Airponix.com | - | 270.7K |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.